STOCK TITAN

Ares Capital Financials

ARCC
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Ares Capital (ARCC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARCC FY2025

Portfolio expansion is being funded externally, while per-share earning power weakens as a larger balance sheet absorbs more capital.

The balance sheet added $7.4B of assets since FY2023, but that extra scale did not lift shareholder efficiency. ROE fell from 13.6% to 9.1%, which means the larger portfolio generated less profit for each shareholder dollar even before considering the higher share count.

Positive net income alongside -$1.72B of operating cash flow in FY2025 shows that cash usage is being driven by investment deployment and repayment timing, not by weak accounting earnings alone. Because the same mismatch appeared in FY2024, cash generation here is tied to how fast the portfolio is expanding year to year, not simply whether reported profit is positive.

With $1.26B of dividends paid against $1.30B of net income, little profit remained inside the company to self-fund growth. That helps explain why long-term debt reached $16.0B and share count kept rising: the model depends on tapping creditors and equity investors rather than retaining much of what it earns for expansion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 19 / 100
Financial Profile 19/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Ares Capital's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage
79

Ares Capital carries a low D/E ratio of 1.12, meaning only $1.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.

Returns
35

Ares Capital's ROE of 9.1% shows moderate profitability relative to equity, earning a score of 35/100. This is down from 11.4% the prior year.

Piotroski F-Score Weak
1/9

Ares Capital passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality
-1.32x

For every $1 of reported earnings, Ares Capital generates $-1.32 in operating cash flow (-$1.7B OCF vs $1.3B net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
$1.3B
YoY-14.7%
5Y CAGR+21.8%

Ares Capital reported $1.3B in net income in fiscal year 2025. This represents a decrease of 14.7% from the prior year.

EPS (Diluted)
$1.86
YoY-23.8%
5Y CAGR+10.3%

Ares Capital earned $1.86 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 23.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$638.0M
YoY+0.5%
5Y CAGR+14.4%

Ares Capital held $638.0M in cash against $16.0B in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.92
YoY+0.0%
5Y CAGR+3.7%

Ares Capital paid $1.92 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
718M
YoY+6.9%
5Y CAGR+11.2%

Ares Capital had 718M shares outstanding in fiscal year 2025. This represents an increase of 6.9% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
9.1%
YoY-2.3pp
5Y CAGR+2.3pp

Ares Capital's ROE was 9.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.3 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

ARCC Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $213.0M N/A $209.0M+11.2% $188.0M+1.1% $186.0M N/A $195.0M+12.1% $174.0M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $92.0M N/A $404.0M+11.9% $361.0M+49.8% $241.0M N/A $394.0M+22.4% $322.0M
EPS (Diluted) $0.13 N/A $0.57+9.6% $0.52+44.4% $0.36 N/A $0.62+19.2% $0.52

ARCC Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $30.7B-1.8% $31.2B+1.4% $30.8B+6.0% $29.1B+2.7% $28.3B+0.2% $28.3B+4.3% $27.1B+3.9% $26.1B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $505.0M-20.8% $638.0M-38.4% $1.0B+131.8% $447.0M-30.9% $647.0M+1.9% $635.0M+30.7% $486.0M-19.1% $601.0M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $16.6B-1.8% $16.9B+2.6% $16.5B+9.6% $15.0B+2.7% $14.6B-1.7% $14.9B+4.0% $14.3B+4.4% $13.7B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $15.8B-0.9% $16.0B+2.5% $15.6B+10.6% $14.1B+1.3% $13.9B+1.4% $13.7B+1.7% $13.5B+4.2% $13.0B
Total Equity $14.1B-1.8% $14.3B0.0% $14.3B+2.1% $14.0B+2.6% $13.7B+2.4% $13.4B+4.6% $12.8B+3.3% $12.4B
Retained Earnings $705.0M-26.4% $958.0M+12.6% $851.0M+7.9% $789.0M+3.1% $765.0M-10.2% $852.0M+17.0% $728.0M+13.4% $642.0M

ARCC Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $184.0M+143.1% -$427.0M+44.8% -$773.0M-254.6% -$218.0M+27.1% -$299.0M-11.6% -$268.0M+48.6% -$521.0M+60.5% -$1.3B
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow -$453.0M-567.0% $97.0M-92.9% $1.4B+873.6% $140.0M-22.7% $181.0M-64.1% $504.0M+8.6% $464.0M-67.4% $1.4B
Dividends Paid $345.0M+8.2% $319.0M-0.3% $320.0M+0.9% $317.0M+2.9% $308.0M+1.7% $303.0M+5.6% $287.0M+2.9% $279.0M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

ARCC Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity 0.7% N/A 2.8%+0.2pp 2.6%+0.8pp 1.8% N/A 3.1%+0.5pp 2.6%
Return on Assets 0.3% N/A 1.3%+0.1pp 1.2%+0.4pp 0.9% N/A 1.5%+0.2pp 1.2%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 1.13+0.0 1.12+0.0 1.09+0.1 1.01-0.0 1.020.0 1.03-0.0 1.060.0 1.05
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Yes, Ares Capital (ARCC) reported a net income of $1.3B in fiscal year 2025.

Ares Capital (ARCC) reported diluted earnings per share of $1.86 for fiscal year 2025. This represents a -23.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Ares Capital (ARCC) had $638.0M in cash and equivalents against $16.0B in long-term debt.

Yes, Ares Capital (ARCC) paid $1.92 per share in dividends during fiscal year 2025.

Ares Capital (ARCC) has a return on equity of 9.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ares Capital (ARCC) generated -$1.7B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ares Capital (ARCC) had $31.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Ares Capital (ARCC) had 718M shares outstanding as of fiscal year 2025.

Ares Capital (ARCC) had a debt-to-equity ratio of 1.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ares Capital (ARCC) had a return on assets of 4.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Ares Capital (ARCC) had $638.0M in cash against an annual operating cash burn of $1.7B. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Ares Capital (ARCC) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ares Capital (ARCC) has an earnings quality ratio of -1.32x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ares Capital (ARCC) scores 19 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top